Thomas Sweeney Heard

Array ( [id] => 4886306 [patent_doc_number] => 20080260638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'RECEPTOR(SSTR2)-SELECTIVE SOMATOSTATIN ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 11/872367 [patent_app_country] => US [patent_app_date] => 2007-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9343 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260638.pdf [firstpage_image] =>[orig_patent_app_number] => 11872367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4644570 [patent_doc_number] => 08022176 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-20 [patent_title] => 'FAS peptide mimetics and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/869556 [patent_app_country] => US [patent_app_date] => 2007-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 14934 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/022/08022176.pdf [firstpage_image] =>[orig_patent_app_number] => 11869556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4487509 [patent_doc_number] => 07884186 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-08 [patent_title] => 'Isotopically labeled trapping agent and method for identifying reactive metabolites' [patent_app_type] => utility [patent_app_number] => 11/860056 [patent_app_country] => US [patent_app_date] => 2007-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 8656 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/884/07884186.pdf [firstpage_image] =>[orig_patent_app_number] => 11860056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4791575 [patent_doc_number] => 20080292548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'COMPOUNDS AND METHODS FOR 18F LABELED AGENTS' [patent_app_type] => utility [patent_app_number] => 11/851910 [patent_app_country] => US [patent_app_date] => 2007-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 66160 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20080292548.pdf [firstpage_image] =>[orig_patent_app_number] => 11851910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720323 [patent_doc_number] => 20080242846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'O-LINKED GLYCOSYLATION OF PEPTIDES' [patent_app_type] => utility [patent_app_number] => 11/843588 [patent_app_country] => US [patent_app_date] => 2007-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 56929 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242846.pdf [firstpage_image] =>[orig_patent_app_number] => 11843588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4650969 [patent_doc_number] => 20080038225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'TRIAZOLYL ACYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/835157 [patent_app_country] => US [patent_app_date] => 2007-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20305 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20080038225.pdf [firstpage_image] =>[orig_patent_app_number] => 11835157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4574183 [patent_doc_number] => 07829669 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-09 [patent_title] => 'Catalytically active recombinant memapsin and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/888920 [patent_app_country] => US [patent_app_date] => 2007-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 20 [patent_no_of_words] => 19763 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/829/07829669.pdf [firstpage_image] =>[orig_patent_app_number] => 11888920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4802682 [patent_doc_number] => 20080014270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'METHODS FOR IMPROVED LIPID METABOLISM AND BASAL METABOLIC RATE WITH LACTOFERRIN' [patent_app_type] => utility [patent_app_number] => 11/832387 [patent_app_country] => US [patent_app_date] => 2007-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 7031 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20080014270.pdf [firstpage_image] =>[orig_patent_app_number] => 11832387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5360477 [patent_doc_number] => 20090035271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'TETRAZOLYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/832240 [patent_app_country] => US [patent_app_date] => 2007-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18530 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20090035271.pdf [firstpage_image] =>[orig_patent_app_number] => 11832240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4939422 [patent_doc_number] => 20080076741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'ENHANCEMENT OF TIGECYCLINE POTENCY USING EFFLUX PUMP INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/832626 [patent_app_country] => US [patent_app_date] => 2007-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 45307 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076741.pdf [firstpage_image] =>[orig_patent_app_number] => 11832626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5360473 [patent_doc_number] => 20090035267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'ACYCLIC, PYRIDAZINONE-DERIVED HEPATITIS C SERINE PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/831474 [patent_app_country] => US [patent_app_date] => 2007-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14312 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20090035267.pdf [firstpage_image] =>[orig_patent_app_number] => 11831474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5447071 [patent_doc_number] => 20090048297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => '4-AMINO-4-OXOBUTANOYL PEPTIDES AS INHIBITORS OF VIRAL REPLICATION' [patent_app_type] => utility [patent_app_number] => 11/777745 [patent_app_country] => US [patent_app_date] => 2007-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20188 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048297.pdf [firstpage_image] =>[orig_patent_app_number] => 11777745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4802586 [patent_doc_number] => 20080014173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Hepatitis C Virus Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/775341 [patent_app_country] => US [patent_app_date] => 2007-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26104 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20080014173.pdf [firstpage_image] =>[orig_patent_app_number] => 11775341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404711 [patent_doc_number] => 20090240026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'Novel Fluorescent Amino Acid Derivative and Production Method Of The Same' [patent_app_type] => utility [patent_app_number] => 12/306784 [patent_app_country] => US [patent_app_date] => 2007-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5367 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20090240026.pdf [firstpage_image] =>[orig_patent_app_number] => 12306784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5199760 [patent_doc_number] => 20070299078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Quinoxalinyl Macrocyclic Hepatitis C Virus Serine Protease Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/768723 [patent_app_country] => US [patent_app_date] => 2007-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19911 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20070299078.pdf [firstpage_image] =>[orig_patent_app_number] => 11768723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8955908 [patent_doc_number] => 08501681 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-06 [patent_title] => 'Macrocyclic hepatitis C virus serine protease inhibitors' [patent_app_type] => utility [patent_app_number] => 11/768712 [patent_app_country] => US [patent_app_date] => 2007-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21272 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11768712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296115 [patent_doc_number] => 20100240591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'TPP II INHIBITORS FOR USE IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES AND TRANSPLANT REJECTION' [patent_app_type] => utility [patent_app_number] => 12/666457 [patent_app_country] => US [patent_app_date] => 2007-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9690 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240591.pdf [firstpage_image] =>[orig_patent_app_number] => 12666457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5123096 [patent_doc_number] => 20070235365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Rapid Acting Drug Delivery Compositions' [patent_app_type] => utility [patent_app_number] => 11/767698 [patent_app_country] => US [patent_app_date] => 2007-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8406 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20070235365.pdf [firstpage_image] =>[orig_patent_app_number] => 11767698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374680 [patent_doc_number] => 20090312241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Macrocyclic Compounds as Antiviral Agents' [patent_app_type] => utility [patent_app_number] => 12/306137 [patent_app_country] => US [patent_app_date] => 2007-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28747 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312241.pdf [firstpage_image] =>[orig_patent_app_number] => 12306137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 151817 [patent_doc_number] => 07678760 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-16 [patent_title] => 'Inhibitors of Memapsin 2 and use thereof' [patent_app_type] => utility [patent_app_number] => 11/763342 [patent_app_country] => US [patent_app_date] => 2007-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 20 [patent_no_of_words] => 19744 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/678/07678760.pdf [firstpage_image] =>[orig_patent_app_number] => 11763342 [rel_patent_id] =>[rel_patent_doc_number] =>)